Clinical Trials

Mohs surgery

Displaying 2 studies

A Study of Vismodegib With Surgery in Patients With Previously Untreated Basal Cell Carcinoma Scottsdale/Phoenix, AZ
This randomized, double-blind, placebo-controlled study will assess the efficacy and safety of vismodegib with surgery in patients with basal cell carcinoma. Patients will be randomized to receive oral daily doses of vismodegib 150 mg or m atching placebo. The anticipated time on study drug treatment is 12 weeks.
Patient Satisfaction in Mohs Micrographic Surgery with Supplemental Lidocaine Jelly Scottsdale/Phoenix, AZ

The purpose of this study is to assess how using lidocaine jelly in Mohs surgery impacts the overall quantity of lidocaine/epinephrine injectable needed to maintain anesthesia, and patients’ pain/anxiety associated with anesthesia injections.